Task: Answer the multiple-choice question.
Question: Which compound exhibits a 4.281% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCN(CC)CCN1C(=O)C(O)=C(C(=O)c2cc3ccccc3o2)C1c1cccnc1
b.) Cc1ccc2oc(=O)c3cnn(CC(=O)NCCN4CCOCC4)c3c2c1
Answer: b. Cc1ccc2oc(=O)c3cnn(CC(=O)NCCN4CCOCC4)c3c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2oc(=O)c3cnn(CC(=O)NCCN4CCOCC4)c3c2c1
Cc1ccc2oc(=O)c3cnn(CC(=O)NCCN4CCOCC4)c3c2c1
2-(8-methyl-4-oxochromeno[4,3-c]pyrazol-1-yl)-N-(2-morpholin-4-ylethyl)acetamide